Home » Previous Page » News Item:

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter

Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter


Fresenius Kabi USA is voluntarily recalling a single lot of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial to the user level due to the presence of particulate matter. Particulate matter was found in reserve sample vials. No adverse event reports have been received

Continue ...

 PDF
Tags:   Recalls    Fresenius    Kabi    Issues    Voluntary    Nationwide    Recall    Ketorolac    Tromethamine    Injection    USP    Due    the    Presence    Particulate    Matter
Rating: 0.00 (0 votes) Rate this article
Bookmark and share this news item: